Page last updated: 2024-10-30

metformin and Capsule Opacification

metformin has been researched along with Capsule Opacification in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.

Research Excerpts

ExcerptRelevanceReference
"To determine the effect of metformin on early Nd:YAG laser treatment for posterior capsule opacification (PCO) and to explore a molecular mechanism to explain a possible protective effect of metformin against PCO."4.02The Protective Effect of Metformin Use on Early Nd:YAG Laser Capsulotomy. ( Christopher, KL; Lynch, AM; Mandava, N; Palestine, AG; Patnaik, JL; Pedler, MG; Petrash, CC; Petrash, JM; Shieh, B; Wagner, BD, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Patnaik, JL1
Christopher, KL1
Pedler, MG1
Shieh, B1
Petrash, CC1
Wagner, BD1
Mandava, N1
Lynch, AM1
Palestine, AG1
Petrash, JM1

Other Studies

1 other study available for metformin and Capsule Opacification

ArticleYear
The Protective Effect of Metformin Use on Early Nd:YAG Laser Capsulotomy.
    Investigative ophthalmology & visual science, 2021, 08-02, Volume: 62, Issue:10

    Topics: Aged; Capsule Opacification; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Laser Therapy;

2021